Multi-organ human-on-a-chip system
Ended Purchase Order Awarded
- Contract number
- 75F40124P00204
- Awardee
-
Tissuse GMBH UEI U5B2KMN56M66
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $60,950
Award facts
- Contract value 50% obligated
-
- $60,950.00 Current, with exercised options
- $120,950.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Germany
Award details come from SAM.gov/FPDS.
About this award
The U.S. Food and Drug Administration (FDA) awarded a $120,950.00 firm fixed-price purchase order contract to Tissuse GMBH, a for-profit organization based in Germany. The contract is for the development of a multi-organ human-on-a-chip system, with a period of performance ending on December 31, 2024. The contract does not have a set-aside designation. Based on the FDA's role in evaluating medical technologies, this contract is likely related to the agency's efforts to advance the development of human organ models for research and testing purposes.
Quick answers
Who was awarded contract 75F40124P00204?
75F40124P00204 was awarded to Tissuse GMBH by Food and Drug Administration (Department of Health and Human Services) on June 24, 2024.
How much is contract 75F40124P00204 worth?
The government has obligated $60,950 on 75F40124P00204. Its potential value, with all options, is $120,950.
Was contract 75F40124P00204 competed?
The extent of competition for 75F40124P00204 was competed under sap. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award